Effects on growth after switching protease inhibitors to efavirenz in HIV-1-infected children

Int J Antimicrob Agents. 2007 Feb;29(2):228-30. doi: 10.1016/j.ijantimicag.2006.09.017. Epub 2006 Dec 28.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Acquired Immunodeficiency Syndrome / physiopathology
  • Adolescent
  • Alkynes
  • Anti-HIV Agents / therapeutic use*
  • Benzoxazines
  • Child
  • Cyclopropanes
  • Female
  • Growth / drug effects*
  • HIV Protease Inhibitors / therapeutic use*
  • HIV-1*
  • Humans
  • Male
  • Oxazines / therapeutic use*

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • HIV Protease Inhibitors
  • Oxazines
  • efavirenz